We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+3.48%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$942M
AUM Growth
+$47.5M
Cap. Flow
+$57.7M
Cap. Flow %
6.13%
Top 10 Hldgs %
36.92%
Holding
174
New
107
Increased
33
Reduced
23
Closed
6

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$22.8M
2
FOLD
Amicus Therapeutics
FOLD
+$16.4M
3
COLL icon
Collegium Pharmaceutical
COLL
+$15.5M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$13.7M
5
AERI
Aerie Pharmaceuticals
AERI
+$10.4M

Top Sells

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$24.4M
2
MOH icon
Molina Healthcare
MOH
+$17.5M
3
EXAS
Exact Sciences
EXAS
+$14.2M
4
PRAH
PRA Health Sciences, Inc.
PRAH
+$13.9M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$11.5M

Sector Composition

Rank Sector Weight
1 Healthcare 84.63%
2 Industrials 0.89%
3 Technology 0.84%
4 Financials 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDGL icon
51
Madrigal Pharmaceuticals
MDGL
$12.6B
$5.54M 0.59%
25,887
-12,262
-32% -$3.08M
SAGE
52
DELISTED
Sage Therapeutics
SAGE
$5.24M 0.56%
37,100
– –
NKTR icon
53
Nektar Therapeutics
NKTR
$2.39B
$5.01M 0.53%
5,484
+576
+12% +$492K
EVLO
54
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$4.96M 0.53%
20,359
-1,516
-7% -$397K
NITE
55
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$4.87M 0.52%
+238,256
New +$4.89M
MASI
56
DELISTED
Masimo
MASI
$4.37M 0.46%
35,102
-7,099
-17% -$787K
SRPT icon
57
Sarepta Therapeutics
SRPT
$1.64B
$4.36M 0.46%
27,000
-178,699
-87% -$24.4M
AGIO icon
58
Agios Pharmaceuticals
AGIO
$2.08B
$4.33M 0.46%
+56,207
New +$4.52M
ESPR
59
DELISTED
Esperion Therapeutics
ESPR
$4.26M 0.45%
96,100
-114,368
-54% -$5.25M
FSTX
60
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$3.51M 0.37%
72,914
+40,000
+122% +$2M
QTTB icon
61
Q32 Bio
QTTB
$435M
$3.28M 0.35%
7,972
– –
MTEM
62
DELISTED
Molecular Templates, Inc.
MTEM
$1.89M 0.2%
+23,333
New +$1.79M
TNDM icon
63
Tandem Diabetes Care
TNDM
$1.27B
$1.84M 0.2%
+42,967
New +$1.5M
ONC
64
BeOne Medicines Ltd
ONC
$33.9B
$1.71M 0.18%
+9,927
New +$1.67M
AGN
65
DELISTED
Allergan plc
AGN
$1.48M 0.16%
+7,771
New +$1.43M
CMTA
66
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
$1.38M 0.15%
123,405
+11,192
+10% +$118K
TMO icon
67
Thermo Fisher Scientific
TMO
$214B
$1.11M 0.12%
+4,549
New +$1.05M
HCM icon
68
HUTCHMED
HCM
$1.96B
$1.02M 0.11%
+31,628
New +$964K
SGEN
69
DELISTED
Seagen Inc. Common Stock
SGEN
$1.01M 0.11%
+13,130
New +$967K
NVTA
70
DELISTED
Invitae Corporation
NVTA
$956K 0.1%
+57,144
New +$650K
ELV icon
71
Elevance Health
ELV
$81.5B
$929K 0.1%
+3,391
New +$880K
ZLAB icon
72
Zai Lab
ZLAB
$2.07B
$876K 0.09%
44,968
-3,700
-8% -$80.2K
ALKS icon
73
Alkermes
ALKS
$8.11B
$874K 0.09%
+20,585
New +$893K
NBIX icon
74
Neurocrine Biosciences
NBIX
$18.2B
$836K 0.09%
+6,803
New +$772K
BDX icon
75
Becton Dickinson
BDX
$46.4B
$787K 0.08%
+3,090
New +$761K
1 2
3
4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Sectoral Asset Management held 174 positions worth $942M, up 5.3% from $894M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Sectoral Asset Management deployed $57.7M of net new capital in Q3 2018, opening 107 new positions and adding to 33 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 76,846 shares worth $14.8M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 85% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Sarepta Therapeutics, an estimated $24.4M trimmed.

  • Sectoral Asset Management's largest Q3 2018 buy was Vertex Pharmaceuticals: 76,846 shares worth $14.8M.
  • Sectoral Asset Management added most to Celgene Corp in Q3 2018, an estimated $22.8M increase.
  • Sectoral Asset Management's biggest Q3 2018 reduction was Sarepta Therapeutics, cutting an estimated $24.4M.
  • Sectoral Asset Management fully exited Molina Healthcare in Q3 2018, selling an estimated $17.5M.
  • Sectoral Asset Management's ten largest holdings make up 37% of its $942M portfolio in Q3 2018.
  • Sectoral Asset Management opened 107 new positions and closed 6 in Q3 2018.
  • Sectoral Asset Management's portfolio value rose 5.3% quarter-over-quarter to $942M.

Based on Sectoral Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.